0
No votes yet
Article

Ocular Graft-Versus-Host Disease After Allogeneic Transplantation

Natasha L. Johnson
CJON 2013, 17(6), 621-626 DOI: 10.1188/13.CJON.621-626

Ocular graft-versus-host disease (GVHD) is a common complication that occurs after allogeneic transplantation. It can cause severe dry eyes that are described as having a burning, gritty, and painful sensation. Ocular GVHD can affect quality of life by causing pain and photophobia, limiting activities of daily living (e.g., reading, watching television), compromising safety while driving, and permanently damaging vision. Pre- and post-transplantation evaluations by an ophthalmologist are recommended. Routine assessments using the National Institutes of Health eye score should be administered to patients at each follow-up visit to their transplantation physician. Treatment options include lubricating eye drops, immunomodulator and steroid drops, and punctal occlusion. Relieving symptoms is difficult, and although multiple treatment options exist, many are ineffective. The Boston Foundation for Sight's scleral lens is an available option that promotes corneal healing and symptom relief. The current article discusses treatment options and supportive care measures for patients with ocular GVHD aimed at relieving symptoms and preventing complications.

References 

Allan, E. J., Flowers, M. E., Lin, M. P., Bensinger, R. E., Martin, P. J., & Wu, M. C. (2011). Visual acuity and anterior segment findings in chronic graft-versus-host disease. <i>Cornea, 30</i>, 1392-1397. doi:10.1097/ICO.0b013e31820ce6d0

Ban, Y., Ogawa, Y., Ibrahim, O. M., Tatematsu, Y., Kamoi, M., Uchino, M., … Tsubota, K. (2011). Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. <i>Molecular Vision, 17</i>, 2533-2543.

Bernauer, W., Thiel, M. A., Kurrer, M., Heiligenhaus, A., Rentsch, K. M., Schmitt, A., … Yanar, A. (2006). Corneal calcification following intensified treatment with sodium hyaluronate artificial tears. <i>British Journal of Ophthalmology, 90</i>, 285-288. doi:10.1136/bjo.2005.082792

Boston Foundation for Sight. (2012). <i>Dry eye and GVHD: How PROSE treatment can help.</i> Retrieved from <a target="_blank" href='http://www.bostonsight.org/content/files/bostonsight_prose_treatment_for...

Choi, S. W., Levine, J. E., & Ferrara, J. L. (2010). Pathogenesis and management of graft-versus-host disease. <i>Immunology and Allergy Clinics of North America, 30</i>, 75-101. doi:10.1016/j.iac.2009.10.001

Coghill, J. M., Sarantopoulos, S., Moran, T. P., Murphy, W. J., Blazar, B. R., & Serody, J. S. (2011). Effector CD4+ T cells, the cytokines they generate, and GVHD: Something old and something new. <i>Blood, 117</i>, 3268-3276. doi:10.1182/blood-2010-12-290403

Couriel, D. R. (2008). Ancillary and supportive care in chronic graft-versus-host disease. <i>Best Practice and Research Clinical Haematology, 21</i>, 291-307. doi:10.1016/j.beha.2008.02.014

Dietrich-Ntoukas, T., Cursiefen, C., Westekemper, H., Eberwein, P., Reinhard, T., Bertz, H., … Wolff, D. (2012). Diagnosis and treatment of ocular chronic graft-versus-host disease: Report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. <i>Cornea, 31</i>, 299-310.

Dignan, F. L., Scarisbrick, J. J., Cornish, J., Clark, A., Amrolia, P., Jackson, G., … Shaw, B. E. (2012). Organ-specific management and supportive care in chronic graft-versus-host disease. <i>British Journal of Haematology, 158</i>, 62-78. doi:10.1111/j.1365-2141.2012.09131.x

Filipovich, A. H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J. R., Lee, S. J., … Flowers, M. E. (2005). National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. <i>Biology of Blood and Marrow Transplantation, 11</i>, 945-956. doi:10.1016/j.bbmt.2005.09.004

Fraser, C. J., Bhatia, S., Ness, K., Carter, A., Francisco, L., Arora, M., … Baker, K. S. (2006). Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: A report from the Bone Marrow Transplant Survivor Study. <i>Blood, 108</i>, 2867-2873. doi:10.1182/blood-2006-02-003954

Inamoto, Y., Chai, X., Kurland, B. F., Cutler, C., Flowers, M. E., Palmer, J. M., … Lee, S. J. (2012). Validation of measurement scales in ocular graft-versus-host disease. <i>Ophthalmology, 119</i>, 487-493.

Inamoto, Y., & Flowers, M. E. (2011). Treatment of chronic graft-versus-host disease in 2011. <i>Current Opinion in Hematology, 18</i>, 414-420. doi:10.1097/MOH.0b013e32834ba87d

Jacobs, D. S. (2008). Update on scleral lenses. <i>Current Opinion in Ophthalmology, 19</i>, 298-301. doi:10.1097/ICU.0b013e328302cc4f

Jacobs, D. S., & Rosenthal, P. (2007). Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. <i>Cornea, 26</i>, 1195-1199.

Lusby, F. W. (2013). Schirmer's test. Retrieved from <a target="_blank" href='http://www.nlm.nih.gov/medlineplus/ency/article/003501.htm'>http://www.n...

Ogawa, Y., & Kuwana, M. (2003). Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. <i>Cornea, 22</i>(Suppl.), S19-S27. doi:10.1097/00003226-200310001-00004

Ogawa, Y., Okamoto, S., Mori, T., Yamada, M., Mashima, Y., Watanabe, R., … Oguchi, Y. (2003). Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. <i>Bone Marrow Transplantation, 31</i>, 579-583. doi:10.1038/sj.bmt.1703862

Riemens, A., Stoyanova, E., Rothova, A., & Kuiper, J. (2012). Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. <i>Molecular Vision, 18</i>, 797-802.

Rosenthal, P., & Cotter, J. (2003). The Boston Scleral Lens in the management of severe ocular surface disease. <i>Ophthalmology Clinics of North America, 16</i>, 89-93. doi:10.1016/S0896-1549(02)00067-6

Rosenthal, P., & Croteau, A. (2005). Fluid-ventilated, gas-permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. <i>Eye and Contact Lens, 31</i>, 130-134. doi:10.1097/01.ICL.0000152492.98553.8D

Sabti, S., Halter, J. P., Braun Fränkl, B. C., & Goldblum, D. (2012). Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GVHD. <i>Bone Marrow Transplantation, 47</i>, 981-984. doi:10.1038/bmt.2011.205

Tabbara, K. F., Al-Ghamdi, A., Al-Mohareb, F., Ayas, M., Chaudhri, N., Al-Sharif, F., … Aljurf, M. (2009). Ocular findings after allogeneic hematopoietic stem cell transplantation. <i>Ophthalmology, 116</i>, 1624-1629. doi:10.1016/j.ophtha.2009.04.054

Takahide, K., Parker, P. M., Wu, M., Hwang, W. Y., Carpenter, P. A., Moravec, C., … Flowers, M. E. (2007). Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. <i>Biology of Blood and Marrow Transplantation, 13</i>, 1016-1021. doi:10.1016/j.bbmt.2007.05.006

Wang, Y., Ogawa, Y., Dogru, M., Kawai, M., Tatematsu, Y., Uchino, M., & Tsubota, K. (2008). Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. <i>Bone Marrow Transplantation, 41</i>, 293-302. doi:10.1038/sj.bmt.1705900

Wang, Y., Ogawa, Y., Dogru, M., Tatematsu, Y., Uchino, M., Kamoi, M., … Tsubota, K. (2010). Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye. <i>Bone Marrow Transplantation, 45</i>, 1077-1083. doi:10.1038/bmt.2009.312

Westeneng, A. C., Hettinga, Y., Lokhorst, H., Verdonck, L., van Dorp, S., & Rothova, A. (2010). Ocular graft-versus-host disease after allogeneic stem cell transplantation. <i>Cornea, 29</i>, 758-763.